Cubist Systematic Strategies, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $3.43 Million - $3.96 Million	-233,967 Reduced 96.49%	8,523 $132,000
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $2.6 Million - $3.37 Million	197,232 Added 435.79%	242,490 $3.87 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $288,044 - $422,775	24,452 Added 117.52%	45,258 $760,000
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $243,222 - $312,506	20,806 New	20,806 $243,000
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $2.05 Million - $3.01 Million	-142,919 Reduced 42.99%	189,495 $3.14 Million
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $3.79 Million - $6.03 Million	-309,386 Reduced 48.21%	332,414 $6.18 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $2.03 Million - $4.46 Million	287,281 Added 81.03%	641,800 $8.23 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $2.03 Million - $4.46 Million	287,281 Added 81.03%	641,800 $8.23 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $342,176 - $470,698	54,924 Added 18.33%	354,519 $2.49 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $223,906 - $350,407	-42,167 Reduced 12.34%	299,595 $2.48 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $1.2 Million - $1.71 Million	229,567 Added 204.61%	341,762 $2.31 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $252,878 - $314,925	52,140 Added 86.82%	112,195 $595,000
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $128,219 - $180,822	29,888 Added 99.08%	60,055 $345,000
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $4,022 - $5,468	-1,166 Reduced 3.72%	30,167 $139,000
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $24,478 - $31,566	-8,242 Reduced 20.83%	31,333 $105,000
Q3 2020 Nov 16, 2020	SELL	$2.97 - $5.08 $629 - $1,076	-212 Reduced 0.53%	39,575 $118,000
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $138,458 - $200,924	39,787 New	39,787 $184,000
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $70,843 - $141,415	-27,143 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $99,614 - $154,715	27,143 New	27,143 $102,000
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $318,225 - $607,818	-81,806 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $220,876 - $499,834	81,806 New	81,806 $314,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $29,007 - $49,286	-12,835 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $30,675 - $51,468	12,835 New	12,835 $31,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$385 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$166 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$128 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$117 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$62.2 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account